Deadly illness in Congo may be malaria, health officials say
KINSHASA, Feb 27 (Reuters) - A condition that has killed at least 50 people in northwest Democratic Republic of Congo this month is suspected to be malaria or food poisoning, local health officials said on Thursday.
At least 943 people have also fallen sick and 52 died in Equateur province, with symptoms ranging from fever and fatigue to vomiting and weight loss, Dieudonne Mwamba, director general of the National Institute of Public Health, said.
The World Health Organization said in a statement it had identified 1,096 cases and 60 deaths fitting the definition of the illness.
"For now, our diagnosis is malaria, and we also suspect food poisoning," Mwamba told Reuters.
"It's not an unknown and mysterious disease. It's a phenomenon involving children who consumed bushmeat."
The WHO said in a bulletin on February 16 it has received reports indicating that children had consumed a bat carcass before the onset of symptoms.
A dozen samples tested negative for viral hemorrhagic fever, while 78% of the samples tested positive for malaria, Mwamba said.
"There are five villages that are affected ... The diagnostic is more pointing toward malaria," Ngashi Ngongo from the Africa Centres for Disease Control and Prevention (Africa CDC) said in a press briefing via video link.
The World Health Organization said it was stepping up surveillance and will work with local health authorities to conduct further investigations.
An outbreak of disease in December, initially of unknown cause, was ultimately identified as malaria.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
9 hours ago
- Daily Mirror
New Covid variant sparks 'unusual' symptoms as doctors warn of rising cases
Doctors have warned people to look out for new symptoms of coronavirus, stressing that the latest strain is different from the rest. People could mistake Covid for other common issues due to the similarities Health officials have issued a warning about a new coronavirus strain which comes with unusual symptoms following a spike in cases. People in Ireland have been urged to stay home for two days if they display any signs of Covid, with the new variant also causing gastrointestinal problems. The variant, labelled NB.1.8.1, has already been flagged in the UK, US and Australia. Experts stressed that although old strains have been linked to flu-like symptoms, NB.1.8.1 can cause gastrointestinal issues such as nausea, vomiting, diarrhoea and heartburn. Patients who experience bloating, constipation and abdominal pain could also find themselves with Covid-19. The World Health Organization (WHO) added the variant to its official watch list and suggested that it is more transmissible than other strains. However, there isn't any evidence to indicate that it causes more acute illnesses. READ MORE: Father's Day gift guide for 2025: Handpicked presents from £7 to suit every kind of dad According to WHO, the strain first appeared in January and by late April it was responsible for around 10.7% of global infections, up from just 2.5% a month earlier. The strain has seen a rapid rise in Ireland in recent weeks. According to data from the Health Protection Surveillance Centre (HPSC), the proportion of sequenced Covid samples linked to NB.1.8.1 jumped from 3.7% to 27.3% in the last five weeks, reports Dublin Live. The variant has also been confirmed in popular holiday hotspots such as Thailand, Egypt and the Maldives. It has already become dominant in parts of Asia, including China and Hong Kong. Dr Lara Herrero, Associate Professor and Virology Research Leader at Griffith University, explained: "Common symptoms [of NB.1.8.1] include sore throat, fatigue, fever, mild cough, muscle aches and nasal congestion. Gastrointestinal symptoms may also occur in some cases." Irish people who find themselves unwell with unseasonal cold symptoms or gastrointestinal issues may actually have Covid, according to the HSE. Ireland's public health guidelines remain the same: If you have any symptoms of Covid, stay at home until 48 hours after the symptoms are mostly or fully gone. You should also avoid contact with other people, especially people at higher risk from Covid. Covid symptoms to look out for Fever (high temperature - 38C or above) - including having chills Dry cough Fatigue (tiredness) Loss or change to your sense of smell or taste – this could mean they're completely gone or just different to normal Nasal congestion (runny or blocked nose) Conjunctivitis (also known as red eye or pink eye) Sore throat Headache Muscle or joint pain (aches and pains) Different types of skin rash Nausea or vomiting Diarrhoea Chills Dizziness Shortness of breath or breathing difficulties Loss of appetite Confusion Pain or pressure in the chest
The Guardian
14 hours ago
- The Guardian
Better alcohol regulation will save lives and money
You are right to argue that rising alcohol harm must be addressed in the government's 10-year health plan (The Guardian view on alcohol and public health: the drinks industry must not control the narrative, 1 June). If ministers are 'staking their reputation on economic growth', they need to deal head-on with one of the biggest drivers of premature death and lost productivity, while ignoring spurious claims made by alcohol companies whose profits have for too long trumped public health. Alcohol harm costs England at least £27bn a year – almost double what the Treasury collects in alcohol duty. These harms aren't incidental to the alcohol market; they are intrinsic to it. While the industry promotes 'moderate drinking', evidence shows that its profits and growth depend on the heaviest drinkers. It's no coincidence that Diageo's CEO recently described moderation as the industry's 'biggest disrupter'. Policies that reduce alcohol consumption are consistently shown to be sound investments, recommended by the Organisation for Economic Co-operation and Development, the World Bank and the World Health Organization. In Scotland, the introduction of minimum unit pricing (MUP) led to a 13% drop in alcohol-specific deaths and a 4% fall in hospital admissions. If adopted in England, MUP could reduce premature mortality while saving the NHS millions and help create a healthier workforce. England urgently needs a national alcohol strategy. Bold, evidence-based measures like MUP must be at its core, with commercial vested-interest groups kept at the Katherine SeveriChief executive, Institute of Alcohol Studies Your editorial reflects the serious concerns that we at World Cancer Research Fund and many other organisations have around the ineffectiveness of England's alcohol regulation. The evidence shows that there is no safe level of alcohol consumption when it comes to cancer risk. And there are around 17,000 alcohol-related cancer cases in the UK every year, as well as 200 other associated health conditions caused by alcohol. In our Cancer Prevention Action Week (23-29 June), we will showcase polling that highlights the chasm between public perception about alcohol and cancer risks. We want the public to have correct health information at their disposal so they can understand their cancer risks and make informed choices. Now is the time for direct action. The UK government urgently needs to join the dots on regulation around alcohol marketing and labelling. We urge members of the public to do their part and sign our petition to advocate with us for better regulation in England. Dr Giota Mitrou Executive director of research and policy, World Cancer Research Fund Nearly half of UK adults now drink alcohol-free products, and our research shows that 68% of them use these drinks to cut down on alcohol. But despite this momentum, outdated labelling rules are holding people back. For over a decade, governments have delayed a straightforward change: allowing drinks at or below 0.5% ABV to be labelled 'alcohol-free'. This is already the international standard and reflects the reality – drinks at this level contain no more alcohol than a ripe banana, sourdough bread or even some soft drinks. Yet UK producers are still forced to use the term 'low alcohol' for these drinks, confusing consumers and deterring many from trying WilloughbyCo-founder, Club Soda Have an opinion on anything you've read in the Guardian today? Please email us your letter and it will be considered for publication in our letters section.
Reuters
3 days ago
- Reuters
Novo's Ozempic, Wegovy linked to rare cases of dangerous eye disorder, EMA says
June 6 (Reuters) - The European Medicines Agency's safety committee has concluded that the use of Novo Nordisk's ( opens new tab popular weight-loss drug Wegovy and its treatments for type 2 diabetes may cause rare occurrences of a potentially dangerous eye condition. Called non-arteritic anterior ischemic optic neuropathy (NAION), the condition may affect up to 1 in 10,000 people taking semaglutide, the active ingredient in Wegovy and Novo's diabetes drugs Ozempic and Rybelsus, the regulator said on Friday. The EMA, which started its review in December, said the use of the drugs is linked to about twofold increase in the risk of developing the condition compared to people not taking the medicine. NAION develops from insufficient blood flow to the optic nerve and causes sudden painless vision loss in one eye. It is the second most common cause of blindness due to optic nerve damage, after glaucoma. Studies have linked semaglutide to NAION in the past. But this is the first time a regulator has made the link. Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists, which work by helping control blood sugar levels and triggering a feeling of fullness. A large study of nearly 350,000 diabetics published earlier this year had showed that the risk of developing NAION more than doubled after long-term use of semaglutide, compared to patients taking medicines from other classes. The EMA said it has reviewed all available data on NAION with semaglutide, including data from non-clinical studies, clinical trials and post-marketing surveillance. It has recommended the drugmaker to update prescribing information for medicines containing semaglutide to include NAION as a side effect with a frequency of "very rare". The U.S. Food and Drug Administration did not immediately respond to a Reuters request for comment.
